Interest in injectable weight loss treatments has grown rapidly across the UK, with Mounjaro and Ozempic frequently compared by patients exploring their options. Although both medicines are widely recognised, access in the UK varies based on licensing, prescribing routes, and regulated availability. Understanding these differences is essential before deciding which treatment may be right for you.
At The Care Pharmacy, we support patients in navigating these options safely and legally. This guide explains the key differences between Mounjaro and Ozempic, with a focus on how accessible each treatment is in the UK. You can complete an online consultation form to review whether treatment is appropriate under clinical guidance.
Mounjaro and Ozempic are both injectable medications that affect appetite regulation and blood sugar control, but they are licensed and prescribed differently in the UK.
Ozempic was originally developed and approved for the management of type 2 diabetes. Although weight loss is a recognised effect, Ozempic is not licensed in the UK specifically for weight management. As a result, access for weight loss purposes is limited.
Mounjaro is also licensed for type 2 diabetes, but it has become widely used through private services for weight management following clinical assessment. This has made Mounjaro more accessible for patients seeking weight loss support through regulated online pharmacies.
Accessibility refers not only to whether a medication exists, but whether patients can legally and safely obtain it for their intended purpose.
These factors mean that, in practice, Mounjaro is often the more accessible option for patients seeking weight loss treatment in the UK.
In the UK, Ozempic prescribing is tightly controlled due to its primary indication for diabetes and ongoing supply pressures. Many NHS and private providers restrict Ozempic prescribing to ensure availability for patients who need it for blood sugar control.
For patients seeking weight loss support, this can create barriers such as:
This does not mean Ozempic is ineffective, but accessibility remains a challenge for weight loss patients.
Mounjaro has become more accessible through private pharmacy led weight loss services. These services operate within UK regulations, requiring a clinical consultation before prescribing and offering ongoing monitoring.
At The Care Pharmacy, Mounjaro is provided as part of a structured service rather than as a standalone medication. This approach supports patient safety, appropriate dosing, and long term success. If you want to explore whether Mounjaro is suitable for you, get in touch with our team for guidance.
| Feature | Mounjaro | Ozempic |
|---|---|---|
| Licensed use in UK | Diabetes, used privately for weight loss | Diabetes only |
| Weight loss access | Available via private services | Limited and restricted |
| Supply stability | Generally more reliable | Ongoing shortages |
| Clinical support | Structured private services | Mainly diabetes clinics |
Choosing between Mounjaro and Ozempic is not just about effectiveness. Accessibility, licensing, safety, and ongoing support all matter. Mounjaro tends to be a more feasible option for many patients in the UK looking for weight loss treatment.
However, suitability depends on individual health history, goals, and tolerance. This is why clinical assessment is essential before starting any injectable weight loss treatment.
To receive personalised guidance on your options, start an online consultation today to help you make an informed decision.
The Care Pharmacy is a regulated online pharmacy offering safe and transparent access to weight loss treatments. We prioritise clinical assessment, patient safety, and ongoing support rather than quick prescribing.
Our service includes:
When comparing Mounjaro vs Ozempic, accessibility is a key consideration for UK patients. While both medications are effective, Mounjaro is currently more accessible for weight loss through regulated private services.
Ready to explore treatment options? Start an online consultation or get in touch with our team for professional advice you can trust.
This blog was written in collaboration with Pharmacy Mentor.
Medically reviewed by
Superintendent Pharmacist
Updated 31 July 2026 · Clinically reviewed The short answer: Retatrutide is not licensed in the UK. It cannot legally be prescribed, sold or supplied here for weight loss, and anything marketed as a “retatrutide pen” or “research peptide” is an illegal, unregulated product. Following the TRIUMPH-2 and TRIUMPH-3 results announced on 23 July 2026, […]
If you are researching weight loss options and trying to decide between gastric sleeve surgery and prescription weight loss medication, the decision is rarely as straightforward as it might first appear — and cost is only one of the factors worth considering carefully. Gastric sleeve surgery (sleeve gastrectomy) is a permanent surgical procedure that removes […]
Thinking of switching your weight loss treatment to The Care Pharmacy? Moving providers doesn’t mean restarting. This guide covers how switching works, what happens to your dose, what to bring, First Dose Video Supervision, transparent pricing for Mounjaro, Wegovy and Saxenda, and how to compare providers safely before you make the move.
Weight Loss · Emerging Treatments Cagrilintide: What It Is, How It Works, and Why It Could Change Weight Loss Medicine Everything you need to know about the next generation of obesity treatment — and what happens when it’s combined with a GLP-1. Updated June 2026 · Medically reviewed · 12 min read Important: This guide […]
Starting a new prescription medication always comes with questions. When that medication is as clinically potent as Mounjaro (tirzepatide), those questions tend to centre on one thing above all else: the side effects. What will they feel like? When will they start? And, perhaps most importantly, how long do Mounjaro side effects last? This guide […]
Starting Mounjaro is one thing. Getting the most from it is another. The clinical evidence for tirzepatide is compelling, but the patients who achieve the best outcomes are not simply those who inject once a week and hope for the best. They are the patients who understand how the medication works, adapt their habits to […]
